Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Aberdeen
About this trial
Acute stress-induced (Takotsubo cardiomyopathy) presents like a heart attack and is triggered by intense emotional or physical stress. Although coronary arteries are unobstructed, it has been suggested that the risk of death is similar to a myocardial infarction. The purpose of the STARR study is to identify all cases of Takotsubo in Scotland since 2010 and assess its epidemiology and outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients diagnosed with Takotsubo cardiomyopathy
Disqualifiers
NA
Trial population
Patients diagnosed with Takotsubo cardiomyopathy in Scotland since 2010
Trial design
Design model
Case-control
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
800 Participants
are grouped into 2 trial groupsGroup A: Takotsubo cardiomyopathy
Group B: Myocardial Infarction
Trial outcomes
Primary outcomes
1
Mortality and morbidity of takotsubo syndrome
To use a nation-wide cohort (and matched national-wide control populations) to establish the all-cause mortality and consequent all cause hospitalisation rates
Time frame
13 yearsSecondary outcomes
1
Specific causes of mortality and morbidity of takotsubo syndrome
To use a nation-wide cohort (and matched national-wide control populations) to establish the specific causes of mortality and morbidities requiring subsequent hospitalisation
Time frame
13 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Aberdeen
Lead sponsor
NHS Tayside
Collaborator
NHS Lothian
Collaborator
NHS Highlands
Collaborator
NHS Ayrshire and Arran
Collaborator
Golden Jubilee National Hospital
Collaborator
NHS Greater Glasgow and Clyde
Collaborator
NHS Lanarkshire
Collaborator
Source ClinicalTrials.gov